Filing Details
- Accession Number:
- 0001225208-11-013359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-06 10:42:48
- Reporting Period:
- 2011-05-04
- Filing Date:
- 2011-05-06
- Accepted Time:
- 2011-05-06 10:42:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1475384 | Iii S Richard Bowles | One Merck Drive Whitehouse Station NJ 08889-0100 | Exe V-P & Chief Compl Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-04 | 29,755 | $22.69 | 106,330 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-04 | 100 | $36.56 | 106,230 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-04 | 2,248 | $36.57 | 103,982 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-04 | 13,300 | $36.56 | 90,682 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-04 | 14,107 | $36.55 | 76,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2011-05-04 | 3,282 | $0.00 | 3,282 | $0.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2011-05-04 | 29,755 | $0.00 | 29,755 | $22.69 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2011-05-04 | 44,776 | $0.00 | 44,776 | $36.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,282 | 2014-05-04 | 2014-05-04 | No | 4 | A | Direct |
| 0 | 2006-04-25 | 2015-04-24 | No | 4 | M | Direct |
| 44,776 | 2012-05-04 | 2021-05-03 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 252 | Indirect | As Custodian |
| Common Stock - 401(K) Plan | 3,592 | Indirect | By 401(k) |
Footnotes
- Includes shares acquired and dividends earned through April 8, 2011, in the MSD Employee Savings and Security Plan, a 401 (k) plan.
- Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- The option vests in three equal annual installments beginning May 4, 2012.
Billionaire Hedge Funds
